{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:25:24Z","timestamp":1777922724309,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175083"],"award-info":[{"award-number":["175083"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175087"],"award-info":[{"award-number":["175087"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jns.2014.07.060","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T02:30:17Z","timestamp":1407292217000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Extrathymic malignancies in a defined cohort of patients with myasthenia gravis"],"prefix":"10.1016","volume":"346","author":[{"given":"I.","family":"Basta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Pekmezovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Peric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Rakocevic-Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Stevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lavrnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2014.07.060_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.jns.2014.07.060_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1548-5315(11)70395-3","article-title":"Update on paraneoplastic neurologic disorders","volume":"7","author":"Dalmau","year":"2010","journal-title":"Community Oncol"},{"key":"10.1016\/j.jns.2014.07.060_bb0015","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00415-009-5091-9","article-title":"Risk factors for tumor occurrence in patients with myasthenia gravis","volume":"256","author":"Citterio","year":"2009","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.jns.2014.07.060_bb0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0277-5379(91)90179-H","article-title":"Extrathymic malignancy in patients with myasthenia gravis","volume":"27","author":"Monden","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jns.2014.07.060_bb0025","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1749-6632.1998.tb11011.x","article-title":"Risk of cancer in patients with myasthenia gravis","volume":"841","author":"Evoli","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2014.07.060_bb0030","doi-asserted-by":"crossref","unstructured":"Pan CC, Chen PC, Wang LS, Chi KH, Chiang H. Thymoma is associated with an increased risk of second malignancy. Cancer 92:2406\u20132411.","DOI":"10.1002\/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7"},{"issue":"3","key":"10.1016\/j.jns.2014.07.060_bb0035","first-page":"360","article-title":"The association of malignancy with rheumatic and connective tissue diseases","volume":"24","author":"Carsons","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jns.2014.07.060_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2005.05.009","article-title":"Extrathymic malignancies in patients with myasthenia gravis","volume":"237","author":"Levin","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2014.07.060_bb0045","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/bjc.1971.79","article-title":"The relationship between thymus and ocnogenesis: a study of the incidence of nonthymic malignancy in myasthenia gravis","volume":"15","author":"Papatestas","year":"1971","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.jns.2014.07.060_bb0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000342777","article-title":"Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979\u20132008","volume":"40","author":"Lavrnic","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2014.07.060_bb0055","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.jns.2014.07.060_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jeretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.07.060_bb0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1468-1331.2011.03621.x","article-title":"Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study","volume":"19","author":"Liu","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2014.07.060_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0404.2006.00612.x","article-title":"Does myasthenia gravis provide protection against cancer?","volume":"183","author":"Owe","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2014.07.060_bb0075","doi-asserted-by":"crossref","unstructured":"Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy\u2014is there an association? Scand J Rheumatol 30:185\u2013188.","DOI":"10.1080\/030097401316909486"},{"key":"10.1016\/j.jns.2014.07.060_bb0080","doi-asserted-by":"crossref","unstructured":"Petterson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in systemic lupus erythematosus. Ann Rheum Dis 51:437\u2013439.","DOI":"10.1136\/ard.51.4.437"},{"issue":"3","key":"10.1016\/j.jns.2014.07.060_bb0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0025-7125(16)31035-5","article-title":"Autoimmunity and malignancy","volume":"69","author":"McCarty","year":"1985","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.jns.2014.07.060_bb0100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bcmd.2001.0442","article-title":"The dual association between lymphoma and autoimmunity","volume":"27","author":"Ehrenfeld","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jns.2014.07.060_bb0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2014.07.060_bb0110","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1365-2036.2002.01297.x","article-title":"Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine","volume":"16","author":"Fraser","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jns.2014.07.060_bb0115","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0041-1345(03)00669-9","article-title":"Influence of immunosuppression on the prevalence of cancer after kidney transplantation","volume":"35","author":"Marcen","year":"2003","journal-title":"Trans Proc"},{"key":"10.1016\/j.jns.2014.07.060_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jns.2009.11.006","article-title":"Extrathymic malignancies in thymoma patients with and without myasthenia gravis","volume":"290","author":"Owe","year":"2010","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.jns.2014.07.060_bb0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.nrl.0000195828.36108.c3","article-title":"Extrathymic tumors in patients with myasthenia gravis: a 35-year retrospective study","volume":"12","author":"Wakata","year":"2006","journal-title":"Neurologist"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14005061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14005061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:43:15Z","timestamp":1758382995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14005061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0022510X14005061"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.07.060","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrathymic malignancies in a defined cohort of patients with myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.07.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}